Pfizer antiviral approved in Canada but supply issues are expected

Health Canada approved Pfizer's antiviral treatment for COVID-19 on Monday, January 17, 2022, which could help cut pressure on the health-care system by preventing high-risk patients from ending up in the hospital.

Related Keywords

United States ,Canada ,Canadians ,Canadian ,Filomena Tassi ,Zain Chagla ,Cdnpoli Covid ,Theresa Tam ,Pfizer ,Mcmaster University ,Public Health Agency Of Canada ,Drug Administration ,Health Canada ,Public Health Agency ,Master University ,Minister Filomena Tassi ,Pfizer Canada ,United States Food ,Canadian Press ,